Ultralife Corp
(ULBI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,104 | -10,240 | -6,120 | -4,910 | -1,920 |
| Depreciation Amortization | 913 | 2,030 | 1,558 | 1,030 | 520 |
| Accounts receivable | -1,039 | N/A | 709 | N/A | N/A |
| Other Working Capital | -1,458 | -450 | -388 | -1,010 | -930 |
| Other Operating Activity | 1,371 | -1,870 | -3,338 | 180 | 120 |
| Operating Cash Flow | $-3,317 | $-10,530 | $-7,579 | $-4,710 | $-2,210 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,520 | -2,940 | -2,109 | -1,700 | -1,180 |
| Purchase Of Investment | -13,972 | N/A | -56,289 | N/A | N/A |
| Sale Of Investment | 13,942 | N/A | 60,809 | N/A | N/A |
| Other Investing Activity | 0 | 9,390 | 0 | 4,240 | 1,310 |
| Investing Cash Flow | $-1,550 | $6,450 | $2,411 | $2,540 | $130 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 423 | N/A | N/A |
| Debt Repayment | -203 | N/A | -69 | N/A | N/A |
| Common Stock Issued | 426 | N/A | 5,175 | N/A | N/A |
| Other Financing Activity | 0 | 9,600 | 0 | 3,620 | 3,230 |
| Financing Cash Flow | $223 | $9,600 | $5,529 | $3,620 | $3,230 |
| Exchange Rate Effect | 45 | -590 | -152 | -20 | 7 |
| Beginning Cash Position | 5,712 | 770 | 776 | 770 | 770 |
| End Cash Position | 1,113 | 5,710 | 985 | 2,210 | 1,930 |
| Net Cash Flow | $-4,599 | $4,930 | $209 | $1,430 | $1,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,317 | -10,530 | -7,579 | -4,710 | -2,210 |
| Capital Expenditure | -1,520 | N/A | -2,109 | N/A | N/A |
| Free Cash Flow | -4,837 | -10,530 | -9,688 | -4,710 | -2,210 |